Fractyl Health has developed a new technology called duodenal mucosal resurfacing, which can "reset" your gut, leading to improvements in glucose levels and weight and a reduction in medications. Learn more about this technology and its performance in current clinical trials. Continue Reading »

Early trial results found that SGLT-2 inhibitor Jardiance is highly effective at preventing and treating kidney disease in people with or without type 2 diabetes. Continue Reading »

Vabysmo, a new drug manufactured by Roche, was recently approved by the FDA to treat two common eye diseases. Find out more about this medication and how it might help you. Continue Reading »

Participating in clinical trials are a way for people with diabetes to be directly involved in the evolution of diabetes care. Julie Heverly shares her experience being hooked up to seven continuous glucose monitors during a clinical trial and why she believes they are so important. Continue Reading »

Learn more about this clinical trial by Novo Nordisk, that is testing whether a new medication, when combined with semaglutide (also known as Wegovy), can help people with type 2 diabetes lower their glucose levels and lose weight.  Continue Reading »

In a collaboration between ViaCyte and CRISPR Therapeutics, a new clinical trial is investigating a stem cell therapy that may eventually help millions with type 1 diabetes. Continue Reading »

Are you currently taking metformin but not meeting your A1C goals? Join a study looking to compare Rybelsus (oral semaglutide) with other oral diabetes drugs to see how it can improve your glucose levels. Continue Reading »

Clinical trials are the middle step between scientific discoveries in the lab and making these discoveries available to the public. Learn how clinical trials work, the experience of participating, and how you can get involved. Continue Reading »